FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998317438> ?p ?o ?g. }

• W1998317438 endingPage "22597" @default.
• W1998317438 startingPage "22591" @default.
• W1998317438 abstract "Membranes prepared after infection of Sf9 cells with recombinant baculovirus containing the rat 5HT2c receptor DNA, but not after infection with wild-type virus, expressed high affinity binding sites for 125I-lysergic acid diethylamide and [3H]mesulergine. The receptor site density reached an optimum of 50-70 pmol/mg membrane protein at 60 h postinfection. Extraction of peripheral membrane proteins from the postnuclear membrane fraction with 6 M urea depleted GTPγS-binding 4-fold without decreasing 5HT2c receptor binding activity. Urea-extracted Sf9 membranes expressing the 5HT2c receptor catalyzed the activation of squid retinal αq but not bovine retinal αt or bovine αo/αi. Productive interaction of 5HT2c receptors with squid αq was enhanced by the addition of βγ dimers prepared from either bovine brain or bovine rod outer segment discs. While the addition of serotonin increased 5HT2c receptor-catalyzed GTPγS binding to αq, the unoccupied receptor was also catalytically active. The 5HT2c receptor antagonists, mesulergine, mianserin, and ketanserin competitively inhibited 5HT activation of the receptor with predicted rank-order affinities; and mianserin and ketanserin markedly inhibited basal 5HT2c receptor activity. Interestingly, this “inverse agonist” efficacy did not correlate with antagonist affinity for the 5HT2c receptor. Baculoviral expression of the 5HT2c receptor and urea extraction of postnuclear Sf9 cell membranes have provided a high density of in situ, uncoupled, G-protein-linked receptor useful for reconstitution with purified G-protein subunits. This has allowed for independent manipulation of receptor and G-protein chemical concentrations and has revealed that a G-protein-linked receptor can possess a significant basal catalytic activity and that antagonist compounds can act as inverse agonists of this basal activity at the level of receptor activation of G-proteins. Membranes prepared after infection of Sf9 cells with recombinant baculovirus containing the rat 5HT2c receptor DNA, but not after infection with wild-type virus, expressed high affinity binding sites for 125I-lysergic acid diethylamide and [3H]mesulergine. The receptor site density reached an optimum of 50-70 pmol/mg membrane protein at 60 h postinfection. Extraction of peripheral membrane proteins from the postnuclear membrane fraction with 6 M urea depleted GTPγS-binding 4-fold without decreasing 5HT2c receptor binding activity. Urea-extracted Sf9 membranes expressing the 5HT2c receptor catalyzed the activation of squid retinal αq but not bovine retinal αt or bovine αo/αi. Productive interaction of 5HT2c receptors with squid αq was enhanced by the addition of βγ dimers prepared from either bovine brain or bovine rod outer segment discs. While the addition of serotonin increased 5HT2c receptor-catalyzed GTPγS binding to αq, the unoccupied receptor was also catalytically active. The 5HT2c receptor antagonists, mesulergine, mianserin, and ketanserin competitively inhibited 5HT activation of the receptor with predicted rank-order affinities; and mianserin and ketanserin markedly inhibited basal 5HT2c receptor activity. Interestingly, this “inverse agonist” efficacy did not correlate with antagonist affinity for the 5HT2c receptor. Baculoviral expression of the 5HT2c receptor and urea extraction of postnuclear Sf9 cell membranes have provided a high density of in situ, uncoupled, G-protein-linked receptor useful for reconstitution with purified G-protein subunits. This has allowed for independent manipulation of receptor and G-protein chemical concentrations and has revealed that a G-protein-linked receptor can possess a significant basal catalytic activity and that antagonist compounds can act as inverse agonists of this basal activity at the level of receptor activation of G-proteins." @default.
• W1998317438 created "2016-06-24" @default.
• W1998317438 creator A5029717334 @default.
• W1998317438 creator A5040322485 @default.
• W1998317438 date "1996-09-01" @default.
• W1998317438 modified "2023-10-05" @default.
• W1998317438 title "Functional Reconstitution of 5-Hydroxytryptamine2c (5HT2c) Receptors with αq and Inverse Agonism of 5HT2c Receptor Antagonists" @default.
• W1998317438 cites W1495372230 @default.
• W1998317438 cites W1500095367 @default.
• W1998317438 cites W1510104405 @default.
• W1998317438 cites W1513811643 @default.
• W1998317438 cites W1518153787 @default.
• W1998317438 cites W1536524213 @default.
• W1998317438 cites W1565364823 @default.
• W1998317438 cites W1565777522 @default.
• W1998317438 cites W1566050966 @default.
• W1998317438 cites W1568965788 @default.
• W1998317438 cites W1570939625 @default.
• W1998317438 cites W1583005424 @default.
• W1998317438 cites W1604834232 @default.
• W1998317438 cites W1960199343 @default.
• W1998317438 cites W1964191104 @default.
• W1998317438 cites W1968862145 @default.
• W1998317438 cites W1972760976 @default.
• W1998317438 cites W1978789853 @default.
• W1998317438 cites W1981058524 @default.
• W1998317438 cites W1987339017 @default.
• W1998317438 cites W2001850627 @default.
• W1998317438 cites W2009164474 @default.
• W1998317438 cites W2019728738 @default.
• W1998317438 cites W2026204366 @default.
• W1998317438 cites W2027283119 @default.
• W1998317438 cites W2029078879 @default.
• W1998317438 cites W2032153694 @default.
• W1998317438 cites W2051072047 @default.
• W1998317438 cites W2058003793 @default.
• W1998317438 cites W2063761685 @default.
• W1998317438 cites W2068315807 @default.
• W1998317438 cites W2073121576 @default.
• W1998317438 cites W2080875376 @default.
• W1998317438 cites W2082497364 @default.
• W1998317438 cites W2091744790 @default.
• W1998317438 cites W2138765408 @default.
• W1998317438 cites W2143966199 @default.
• W1998317438 cites W2162213293 @default.
• W1998317438 cites W2216415241 @default.
• W1998317438 cites W2399950661 @default.
• W1998317438 cites W2409197986 @default.
• W1998317438 cites W2754205450 @default.
• W1998317438 cites W4248350370 @default.
• W1998317438 doi "https://doi.org/10.1074/jbc.271.37.22591" @default.
• W1998317438 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8798428" @default.
• W1998317438 hasPublicationYear "1996" @default.
• W1998317438 type Work @default.
• W1998317438 sameAs 1998317438 @default.
• W1998317438 citedByCount "88" @default.
• W1998317438 countsByYear W19983174382012 @default.
• W1998317438 countsByYear W19983174382013 @default.
• W1998317438 countsByYear W19983174382014 @default.
• W1998317438 countsByYear W19983174382015 @default.
• W1998317438 countsByYear W19983174382016 @default.
• W1998317438 countsByYear W19983174382017 @default.
• W1998317438 countsByYear W19983174382018 @default.
• W1998317438 countsByYear W19983174382019 @default.
• W1998317438 countsByYear W19983174382020 @default.
• W1998317438 countsByYear W19983174382022 @default.
• W1998317438 countsByYear W19983174382023 @default.
• W1998317438 crossrefType "journal-article" @default.
• W1998317438 hasAuthorship W1998317438A5029717334 @default.
• W1998317438 hasAuthorship W1998317438A5040322485 @default.
• W1998317438 hasBestOaLocation W19983174381 @default.
• W1998317438 hasConcept C170493617 @default.
• W1998317438 hasConcept C2775864247 @default.
• W1998317438 hasConcept C2777785214 @default.
• W1998317438 hasConcept C53910766 @default.
• W1998317438 hasConcept C55493867 @default.
• W1998317438 hasConcept C75184817 @default.
• W1998317438 hasConcept C80631254 @default.
• W1998317438 hasConcept C86803240 @default.
• W1998317438 hasConceptScore W1998317438C170493617 @default.
• W1998317438 hasConceptScore W1998317438C2775864247 @default.
• W1998317438 hasConceptScore W1998317438C2777785214 @default.
• W1998317438 hasConceptScore W1998317438C53910766 @default.
• W1998317438 hasConceptScore W1998317438C55493867 @default.
• W1998317438 hasConceptScore W1998317438C75184817 @default.
• W1998317438 hasConceptScore W1998317438C80631254 @default.
• W1998317438 hasConceptScore W1998317438C86803240 @default.
• W1998317438 hasIssue "37" @default.
• W1998317438 hasLocation W19983174381 @default.
• W1998317438 hasOpenAccess W1998317438 @default.
• W1998317438 hasPrimaryLocation W19983174381 @default.
• W1998317438 hasRelatedWork W150066606 @default.
• W1998317438 hasRelatedWork W1949767370 @default.
• W1998317438 hasRelatedWork W1967018240 @default.
• W1998317438 hasRelatedWork W1973812252 @default.
• W1998317438 hasRelatedWork W2038321745 @default.
• W1998317438 hasRelatedWork W2069112908 @default.
• W1998317438 hasRelatedWork W2083855882 @default.

• next